Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Bio Key International (BKYI) over the last 5 years, with Q1 2025 value amounting to $15000.0.

  • Bio Key International's Asset Writedowns and Impairment fell 8500.0% to $15000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$99130.0, marking a year-over-year decrease of 11003.72%. This contributed to the annual value of -$213005.0 for FY2024, which is 10593.91% down from last year.
  • Latest data reveals that Bio Key International reported Asset Writedowns and Impairment of $15000.0 as of Q1 2025, which was down 8500.0% from -$114130.0 recorded in Q4 2024.
  • Bio Key International's 5-year Asset Writedowns and Impairment high stood at $1.1 million for Q4 2023, and its period low was -$114130.0 during Q4 2024.
  • Its 3-year average for Asset Writedowns and Impairment is $376499.4, with a median of $100000.0 in 2024.
  • Over the last 5 years, Bio Key International's Asset Writedowns and Impairment had its largest YoY gain of 8000.0% in 2024, and its largest YoY loss of 11050.44% in 2024.
  • Bio Key International's Asset Writedowns and Impairment (Quarter) stood at $1.1 million in 2023, then crashed by 110.5% to -$114130.0 in 2024, then soared by 113.14% to $15000.0 in 2025.
  • Its last three reported values are $15000.0 in Q1 2025, -$114130.0 for Q4 2024, and -$98875.0 during Q3 2024.